| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |